Announcement
25 September 2023

Take an active role in shaping the programme of UICC’s World Cancer Congress 2024!

UICC is pleased to announce that the call for sessions for World Cancer Congress 2024 is now open for submissions until 12 November.

Dynamic, timely and innovative sessions with engaging speakers are essential to delivering a Congress that resonates with participants and the global health community.

The call for sessions also presents a significant opportunity for organisations and individuals to share their insights into to the challenges facing cancer organisations and cancer care delivery with a diverse, global audience.

UICC therefore invites interested parties to submit their session proposals by 12 November 2023. Take an active role in shaping the programme of World Cancer Congress 2024 next September 2024 in Geneva, Switzerland!

For comprehensive information on the submission process, guidelines, and the six overarching themes of the 2024 Congress, please visit our dedicated Programmes page.

Learn more about the call for sessions for World Cancer Congress 2024 here

Each accepted session proposal will be granted up to five complimentary registrations for the World Cancer Congress 2024.

For any further queries, please do not hesitate to contact UICC Events Team at congress@uicc.org.

Last update

Friday 29 September 2023

Share this page

Related content

Several people at an event in discussion, focus on a woman wearing a headscarf

The preliminary programme for the World Cancer Congress 2026 is now available, highlighting high‑level sessions curated by an Expert Programme Committee and aligned with the Congress themes. Abstract submissions, registration at the lowest rate and partnership opportunities remain open.

Two women and a man in suit receiving an award on stage

Researchers and professionals are invited to submit by 1 April 2026 abstracts that address key challenges in cancer prevention, treatment, and care, with the potential to attract media interest and a chance to shape global cancer control.